Article Text

Download PDFPDF
CASE REPORT
Life-threatening bleeding due to persistent dabigatran effect in a patient with sepsis despite idarucizumab therapy and haemodialysis
  1. Kathryn Humphries1,
  2. Paul Huggan2,
  3. Martin Stiles3 and
  4. Robert Martynoga4
  1. 1 Medicine, Waikato District Health Board, Hamilton, New Zealand
  2. 2 Infectious Diseases and General Medicine, Waikato District Health Board, Hamilton, New Zealand
  3. 3 Cardiology, Waikato District Health Board, Hamilton, New Zealand
  4. 4 Intensive Care and Anaesthetics, Waikato District Health Board, Hamilton, New Zealand
  1. Correspondence to Dr Kathryn Humphries, kathumphries86{at}gmail.com

Footnotes

  • Contributors KH: review of the case notes, literature review and writing of the manuscript. PH: contribution to conception and design, revision and approval of manuscript and accountability for results and conclusions. MS: contribution to conception and design, revision and approval of manuscript. RM: contribution to revision and approval of manuscript with particular attention to the aspects of intensive care interventions.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Parental/guardian consent obtained.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors KH: review of the case notes, literature review and writing of the manuscript. PH: contribution to conception and design, revision and approval of manuscript and accountability for results and conclusions. MS: contribution to conception and design, revision and approval of manuscript. RM: contribution to revision and approval of manuscript with particular attention to the aspects of intensive care interventions.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Parental/guardian consent obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.